www.fgks.org   »   [go: up one dir, main page]

Last update:

Diseases, Conditions, Syndromes news

Diseases, Conditions, Syndromes

WHO chief to 'push until we get the answer' on Covid origins

The World Health Organization will continue pushing until it finds an answer to how the COVID-19 pandemic started, the agency's chief said Wednesday following a report suggesting it had abandoned the search.

Diseases, Conditions, Syndromes

Mpox still a global health crisis: WHO

The World Health Organization said Wednesday that despite a drop-off in cases, it still considers mpox, previously known as monkeypox, an international health emergency.

Medications

Migraine drug shows promise in treatment of acute kidney injury

The drug lasmiditan, which is used to treat migraines, shows promise as a possible treatment for acute kidney injury, according to a new study from the University of Arizona. The findings are published ahead of print in the ...

Diseases, Conditions, Syndromes

Sensory cells taste cerebrospinal fluid to fight brain infections

Sensory neurons pick up information from our senses and relay it to the rest of the nervous system. But this is not their only mission. In a new study published in the journal Current Biology, Claire Wyart at the Paris Brain ...

Medical research

Scientists develop mouse model to study mpox virulence

Scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have removed a major roadblock to better understanding of mpox (formerly, monkeypox). They developed ...

Diseases, Conditions, Syndromes

Why severe fatty liver leads to liver damage

In hepatic steatosis, hepatocytes "die," resulting in liver damage. Severe steatosis increases hepatocellular deaths, thus aggravating liver damage. The mechanism is unclear. Using mice, we show that mild steatosis causes ...

Diseases, Conditions, Syndromes

Lingering symptoms are common after COVID hospitalization

About half of adults treated at hospitals for COVID-19 have experienced lingering symptoms, financial difficulties, or physical limitations months after being discharged, according to a study published in JAMA Network Open.

Diseases, Conditions, Syndromes

Researcher identifies potential cause of 'long COVID'

Even though the COVID-19 public health emergency classification will expire this spring, the lingering effects of the pandemic remain. A constant puzzle to solve since the first year of the pandemic has been "long COVID," ...

Diseases, Conditions, Syndromes

New screening tool to help primary care physicians diagnose COPD

A new tool shows promise in helping primary care physicians identify adults with undiagnosed chronic obstructive pulmonary disease (COPD), according to research published in JAMA. More than 15 million Americans have been ...

Diseases, Conditions, Syndromes

Study shows new route for dangerous coronavirus strain emergence

The immune system fights the coronavirus with antibodies and T cells. Scientists have a fairly good idea of how the virus avoids antibodies, including those promoted by vaccination, which is how variants of concern such as ...

Diseases, Conditions, Syndromes

A new class of antibodies against COVID-19 is being put to the test

A new class of SARS-CoV-2 antibodies has been shown to neutralize multiple variants of the virus, providing hope for a better antiviral medication to prevent and treat COVID-19 symptoms in at-risk individuals, according to ...

Diseases, Conditions, Syndromes

Verified: COVID-19 infection increases diabetes risk

Investigators in the Smidt Heart Institute at Cedars-Sinai have confirmed that people who have had COVID-19 have an increased risk for new-onset diabetes—the most significant contributor to cardiovascular disease.

Diseases, Conditions, Syndromes

Chest CT shows lung abnormalities two years after COVID

Chest CT revealed persistent lung abnormalities in patients two years after COVID-19, according to a study published in Radiology. This is the first research paper with two-year follow-up data on COVID-19 lung effects.

Quantcast